792 related articles for article (PubMed ID: 28143584)
21. The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells.
Allen WL; McLean EG; Boyer J; McCulla A; Wilson PM; Coyle V; Longley DB; Casero RA; Johnston PG
Mol Cancer Ther; 2007 Jan; 6(1):128-37. PubMed ID: 17237273
[TBL] [Abstract][Full Text] [Related]
22. Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells.
Zhang Q; Liu RX; Chan KW; Hu J; Zhang J; Wei L; Tan H; Yang X; Liu H
J Exp Clin Cancer Res; 2019 Jul; 38(1):320. PubMed ID: 31324203
[TBL] [Abstract][Full Text] [Related]
23. Frondoside A Enhances the Anti-Cancer Effects of Oxaliplatin and 5-Fluorouracil on Colon Cancer Cells.
Attoub S; Arafat K; Khalaf T; Sulaiman S; Iratni R
Nutrients; 2018 May; 10(5):. PubMed ID: 29724012
[TBL] [Abstract][Full Text] [Related]
24. Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil.
Liu T; Wang X; Hu W; Fang Z; Jin Y; Fang X; Miao QR
Neoplasia; 2019 Jun; 21(6):557-570. PubMed ID: 31042625
[TBL] [Abstract][Full Text] [Related]
25. The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells.
Pedraz-Cuesta E; Christensen S; Jensen AA; Jensen NF; Bunch L; Romer MU; Brünner N; Stenvang J; Pedersen SF
BMC Cancer; 2015 May; 15():411. PubMed ID: 25981639
[TBL] [Abstract][Full Text] [Related]
26. MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells.
Park JM; Huang S; Tougeron D; Sinicrope FA
PLoS One; 2013; 8(5):e65369. PubMed ID: 23724141
[TBL] [Abstract][Full Text] [Related]
27. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan.
Boyer J; McLean EG; Aroori S; Wilson P; McCulla A; Carey PD; Longley DB; Johnston PG
Clin Cancer Res; 2004 Mar; 10(6):2158-67. PubMed ID: 15041737
[TBL] [Abstract][Full Text] [Related]
28. Translationally controlled tumor protein is a novel biological target for neurofibromatosis type 1-associated tumors.
Kobayashi D; Hirayama M; Komohara Y; Mizuguchi S; Wilson Morifuji M; Ihn H; Takeya M; Kuramochi A; Araki N
J Biol Chem; 2014 Sep; 289(38):26314-26326. PubMed ID: 25092287
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer.
Zhang Y; Geng L; Talmon G; Wang J
J Biol Chem; 2015 Mar; 290(10):6215-25. PubMed ID: 25616665
[TBL] [Abstract][Full Text] [Related]
30. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
Hu J; Cai G; Xu Y; Cai S
Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy-induced
Wang F; Zhao L; Zhang J; Meng Z; Zhou C; Wang G; Liu Y; Li M; Xi J; Niu W; Wang G
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30429233
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
[TBL] [Abstract][Full Text] [Related]
33. [MiR-145 inhibits drug resistance to Oxaliplatin in colorectal cancer cells through regulating G protein coupled receptor 98].
Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):566-570. PubMed ID: 28534337
[TBL] [Abstract][Full Text] [Related]
34. Microarray Analysis of Long Non-coding RNA Expression Profile Associated with 5-Fluorouracil-Based Chemoradiation Resistance in Colorectal Cancer Cells.
Xiong W; Jiang YX; Ai YQ; Liu S; Wu XR; Cui JG; Qin JY; Liu Y; Xia YX; Ju YH; He WJ; Wang Y; Li YF; Hou Y; Wang L; Li WH
Asian Pac J Cancer Prev; 2015; 16(8):3395-402. PubMed ID: 25921151
[TBL] [Abstract][Full Text] [Related]
35. Exogenous interleukin-1α signaling negatively impacts acquired chemoresistance and alters cell adhesion molecule expression pattern in colorectal carcinoma cells HCT116.
Grigaitis P; Jonusiene V; Zitkute V; Dapkunas J; Dabkeviciene D; Sasnauskiene A
Cytokine; 2019 Feb; 114():38-46. PubMed ID: 30583087
[TBL] [Abstract][Full Text] [Related]
36. Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis.
Bras-Gonçalves RA; Pocard M; Formento JL; Poirson-Bichat F; De Pinieux G; Pandrea I; Arvelo F; Ronco G; Villa P; Coquelle A; Milano G; Lesuffleur T; Dutrillaux B; Poupon MF
Gastroenterology; 2001 Mar; 120(4):874-88. PubMed ID: 11231942
[TBL] [Abstract][Full Text] [Related]
37. The role of p62 in cell death and survival of 5-fluorouracil and oxaliplatin-resistant colorectal cancer cells.
Zitkute V; Jasinevicius A; Vaitiekaite G; Kukcinaviciute E; Aleksandraviciute B; Eidenaite E; Sudeikis L; Jonusiene V; Sasnauskiene A
J Cell Biochem; 2023 Nov; 124(11):1779-1791. PubMed ID: 37842885
[TBL] [Abstract][Full Text] [Related]
38. NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling.
Fang Z; Gong C; Yu S; Zhou W; Hassan W; Li H; Wang X; Hu Y; Gu K; Chen X; Hong B; Bao Y; Chen X; Zhang X; Liu H
Cancer Lett; 2018 Feb; 415():58-72. PubMed ID: 29203250
[TBL] [Abstract][Full Text] [Related]
39. Nitrogen permease regulator-like 2 enhances sensitivity to oxaliplatin in colon cancer cells.
Liu MN; Liu AY; Du YJ; Pei FH; Wang XH; Chen J; Liu D; Liu BR
Mol Med Rep; 2015 Jul; 12(1):1189-96. PubMed ID: 25777765
[TBL] [Abstract][Full Text] [Related]
40. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K
Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
